Status:
TERMINATED
Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD)
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Older adults having chronic kidney disease (CKD) have a higher rate of fracture than those without chronic kidney disease. Osteoporosis and chronic kidney disease mineral and bone disorder (CKD-MBD) a...
Detailed Description
Background: Older adults having chronic kidney disease (CKD) have a higher rate of fracture. Osteoporosis and chronic kidney disease mineral and bone disorder (CKD-MBD) are risk factors for skeletal f...
Eligibility Criteria
Inclusion
- Age \> 50 years
- Chronic kidney disease stage 3-4, and estimated glomerular filtration rate \> 20 mL/min/1.73m2
- Fracture Risk Assessment Tool (FRAX®) screening: risk of hip fracture (HF) and major osteoporotic fracture (MOF) (HF: men \> 6%, women \> 7%; MOF: men \> 15%, women \> 12.5%).
- Have ability to sign inform consent and agree with being follow-up for one year.
Exclusion
- Have cancer under treatment.
- Have acute coronary syndrome (unstable angina, non ST-elevation myocardial infarction, ST-segment elevation myocardial infarction) or stroke in 3 months. (ST segment is the flat, isoelectric section of the ECG between the end of the S wave and the beginning of the T wave.)
- Limited cognitive or physical function for execute the intervention.
Key Trial Info
Start Date :
February 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04271605
Start Date
February 14 2020
End Date
December 31 2020
Last Update
June 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital, Chu-Tung Branch
Hsinchu, Taiwan, 310